Presenting our recent collaborative research paper on MXene use for PPT anticancer therapy, the biocompatibility of MXenes in vitro and in vivo studies:
Sergiy Kyrylenko, Oleksiy Gogotsi, Ivan Baginskiy, Vitalii Balitskyi, Veronika Zahorodna, Yevheniia Husak, Ilya Yanko, Mykolay Pernakov, Anton Roshchupkin, Mykola Lyndin, Bernhard B. Singer, Volodymyr Buranych, Alexander Pogrebnjak, Oksana Sulaieva, Oleksandr Solodovnyk, Yury Gogotsi, Maksym Pogorielov, MXene-Assisted Ablation of Cells with a Pulsed Near-Infrared Laser. ACS Appl. Mater. Interfaces 2022, 14, 25, 28683–28696, https://doi.org/10.1021/acsami.2c08678
|